Exosomes derived from metastatic breast cancer cells drive signaling pathways for PI3K/AKT mitogen-activated protein kinase (MAPK), which stimulate migration and invasion of cancer cells by degrading ECM components (Hendrix et al., 2010). This evidence concerns the gene AKT1 and cancer.